
News|Podcasts|October 18, 2022
How AI and Real World Data are Reshaping Medical Affairs
Author(s)IQVIA
Real world data (RWD) and artificial intelligence (AI) offer an unprecedented opportunity for Medical Affairs professionals to gather and share deeper insights about patients, including insights regarding disease progression, outcomes, and treatment response, as well as additional insights about patients’ journeys prior to diagnosis and after treatment initiation. Cindy Weber, of IQVIA’s Artificial Intelligent Solutions team explains how embracing RWD and technology, and the opportunities they provide, is helping to transform Medical Affairs and is enabling professionals to create better, more meaningful, connections with healthcare professionals; thereby helping to improve patient care.
Trending on PharmExec
1
The Biotech Industry’s Relationship with Real-Time Data: Q&A with Dr. Richard Graham
2
Does FDA's Shift From Two Pivotal Trials to One Represent a Genuine Evolution?
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Pharmaceutical Executive Daily: FDA Approves Datroway
5




